Search results (12)
« Back to PublicationsTocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
Horby P. et al, (2021), Lancet, 398
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
RECOVERY Collaborative Group ., (2021), Lancet, 397, 2049 - 2059
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium . et al, (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group . et al, (2021)